RTW Investments’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-7,309,383
| Closed | -$44.1M | – | 68 |
|
|
2019
Q4 | $44.1M | Sell |
7,309,383
-6,555,000
| -47% | -$37.9M | 1.66% | 21 |
|
|
2019
Q3 | $49.9M | Hold |
13,864,383
| – | – | 2.97% | 11 |
|
|
2019
Q2 | $37.2M | Buy |
13,864,383
+115,000
| +0.8% | +$340K | 1.98% | 15 |
|
|
2019
Q1 | $40.7M | Hold |
13,749,383
| – | – | 2.78% | 11 |
|
|
2018
Q4 | $21.9M | Buy |
13,749,383
+153,679
| +1% | +$434K | 2.01% | 15 |
|
|
2018
Q3 | $50M | Buy |
13,595,704
+53,707
| +0.4% | +$160K | 3% | 10 |
|
|
2018
Q2 | $38.3M | Buy |
13,541,997
+45,095
| +0.3% | +$154K | 2.76% | 10 |
|
|
2018
Q1 | $50.1M | Sell |
13,496,902
-50,000
| -0.4% | -$164K | 4.77% | 6 |
|
|
2017
Q4 | $39M | Buy |
13,546,902
+5,707,136
| +73% | +$20.7M | 6.51% | 6 |
|
|
2017
Q3 | $35.2M | Buy |
7,839,766
+6,249,312
| +393% | +$27.7M | 6.13% | 7 |
|
|
2017
Q2 | $7.3M | Buy |
+1,590,454
| New | +$6.39M | 1.54% | 18 |
|
|
2017
Q1 | – | Sell |
-286,285
| Closed | -$1.18M | – | 34 |
|
|
2016
Q4 | $1.18M | Sell |
286,285
-1,922,464
| -87% | -$10.2M | 0.44% | 22 |
|
|
2016
Q3 | $17.9M | Sell |
2,208,749
-215,387
| -9% | -$1.83M | 5.41% | 7 |
|
|
2016
Q2 | $18.9M | Sell |
2,424,136
-134,723
| -5% | -$1.16M | 6.46% | 4 |
|
|
2016
Q1 | $19.8M | Buy |
2,558,859
+569,945
| +29% | +$4.17M | 7.17% | 4 |
|
|
2015
Q4 | $21.5M | Sell |
1,988,914
-600,904
| -23% | -$5.46M | 6.98% | 6 |
|
|
2015
Q3 | $17.9M | Buy |
2,589,818
+74,385
| +3% | +$606K | 5.56% | 6 |
|
|
2015
Q2 | $22.3M | Buy |
2,515,433
+892,800
| +55% | +$8.44M | 6.49% | 4 |
|
|
2015
Q1 | $16M | Hold |
1,622,633
| – | – | 7.22% | 8 |
|
|
2014
Q4 | $19.9M | Buy |
+1,622,633
| New | +$19.8M | 7.35% | 5 |
|
RTW Investments's ACHN Position: Q1 2020 in Review
RTW Investments sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 7,309,383 shares — an estimated $44.1M sold.
RTW Investments first reported a position in ACHN in Q4 2014 and held it in 20 quarters. The position peaked at $50.1M in Q1 2018. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- RTW Investments reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- RTW Investments sold 7,309,383 Achillion Pharmaceuticals shares in Q1 2020, an estimated $44.1M.
- RTW Investments first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 20 quarters.
- RTW Investments's Achillion Pharmaceuticals position peaked at $50.1M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on RTW Investments's 13F filing for Q1 2020, filed 15 May 2020.